Abbott i-STAT 1, System Manual

Page: 445 / 658

Rev. Date: 01-Aug-11 Art: 714179-00L
iCa - 5
References
1. D.S. Young, Effects of Drugs on Clinical Laboratory Tests, 3rd ed. (Washington, DC: American
Association of Clinical Chemistry, 1990).
2. P.C. Painter, J.Y. Cope, J.L. Smith, “Reference Ranges, Table 41–20” in Tietz Textbook of Clinical
Chemistry—Second Edition, C.A. Burtis and E.R. Ashwood, eds. (Philadelphia: W.B. Saunders Company, 1994).
3. CLSI.
Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. CLSI
document EP9-A [ISBN 1-56238-283-7]. CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania
19087-1898, USA 1995.
4. P.J. Cornbleet and N. Gochman, “Incorrect Least-Squares Regression Coefficients in Method-
Comparison Analysis,” Clinical Chemistry 25:3, 432 (1979).
5. See Reference 7.
6. D. Fraser, G. Jones, S.W. Kooh, and I. Raddle, “Calcium and Phosphate Metabolism” in Tietz Textbook
of Clinical Chemistry—Second Edition, C.A. Burtis and E.R. Ashwood, eds. (Philadelphia: W.B. Saunders
Company, 1994).
7 Clinical and Laboratory Standards Institute (CLSI).
Interference Testing in Clinical Chemistry;
Approved Guideline-Second Edition. CLSI document EP7-A2 (ISBN 1-56238-584-4). Clinical and
Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898,
USA 2005.
8 Whillier S, Raftos JE, Chapman B, Kuchel PW. Role of N-acetylcysteine and cystine in glutathione
synthesis in human erythrocytes. Redox Rep. 2009;14(3):115-24.
9 Paolo Ventura, Rossana Panini, Maria CristinaPasini,, Gabriella Scarpetta and Gianfranco Salvioli. N
-Acetyl-Cysteine Reduces Homocysteine Plasma Levels After Single Intravenous Adminstration by Increasing
Thiols Urinary Excretion. Pharmacological Research. Volume 40, Issue 4, October 1999, Pages 345-350.
10 Gillian M. Borthwick, A. Sarah Johnson, Matthew Partington, John Burn, Robert Wilson and Helen M.
Arthur. Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-
independent mechanism. The FASEB Journal. 2006;20:2009-2016.
11 Kharasch E.D, Hankins D., Mautz D., Thummel K.E.. Identification of the enzyme responsible for oxidative
halothane metabolism: implications for prevention of halothane hepatitis. Lancet 1996; 347:1367-71.
12 Morrison J.E., Friesen R.H., Elevated serum bromide concentrations following repeated halothane
anaesthesia in a child. Can J Asaesth 1990; 37 (7): 801-803.
13 Hankins D.C, Kharasch E.D., Determination of the halothane metabolites trifluoroacetic acid and
bromide in plasma and urine by ion chromatography. J of Chromatography B. 692 (1997) 413-418.
14 Charles R.A, Bee Y.M, Eng P.H.K., Goh S.Y. Point of care blood ketone testing: screening for diabetic
ketoacidosis at the emergency department. Singapore Med J 2007; 48 (11): 986.
i-STAT is a registered trademark of the Abbott Group of Companies in various jurisdictions. Vacutainer is a registered trademark of Becton Dickinson
and Company, Franklin Lakes, NJ USA. ICA 1 is a trademark of Radiometer Medical A/S, Copenhagen, Denmark. Stat Profile is a registered
trademark of Nova Biomedical, Waltham, MA USA. Normosol is a trademark of Abbott Laboratories, Abbott Park, IL, USA. Plasma-Lyte is a registered
trademark of Baxter International Inc., Deerfield, IL, USA. Isolyte is a trademark of B. Braun Medical Inc., Germany.